HNSN Insider Trading Activity and SEC Form 4 Filings
HNSN insider trading summary
No open-market insider purchases or sales of Hansen Medical Inc (HNSN) have been reported on SEC Form 4 in the past 12 months.
Latest HNSN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 8, 2016 | Cary Guy Vance | President and CEO | Sell | $2K (596 @ $3.99) |
| Jun 8, 2016 | Brian Sheahan | VP, Regulatory, Clinical & QA | Sell | $662 (166 @ $3.99) |
| Mar 7, 2016 | Brian Sheahan | VP, Regulatory, Clinical & QA | Sell | $404 (161 @ $2.51) |
| Feb 12, 2016 | Robert O Cathcart | SVP, Global Sales | Sell | $665 (284 @ $2.34) |
| Feb 12, 2016 | Joseph James Guido | VP, Marketing & Business Dev | Sell | $5K (2,000 @ $2.34) |
| Feb 12, 2016 | Brian Sheahan | VP, Regulatory, Clinical & QA | Sell | $8K (3,472 @ $2.34) |
| May 12, 2015 | Oracle Associates LLC | 10% Owner | Buy | $8.2M (12,592,453 @ $0.65) |
| May 12, 2015 | Oracle Partners LP | 10% Owner | Buy | $2.6M (3,934,886 @ $0.65) |
| May 12, 2015 | Oracle Partners LP | 10% Owner | Buy | $8.2M (12,592,453 @ $0.65) |
| May 12, 2015 | Larry N Feinberg | 10% Owner | Buy | $8.2M (12,592,453 @ $0.65) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.